Isaac Kennedy

Isaac Kennedy is an accomplished professional with extensive experience in chemical and pharmaceutical manufacturing. Currently serving as Executive Director at Exelixis since May 2022, Isaac provides strategic planning and technical expertise in API development and commercial manufacturing. Prior to this role, Isaac was the General Manager and Site Head at Curia, overseeing multiple departments and managing over 300 employees. Previous positions include Director of Technical Operations Strategy at Relypsa, Senior Manager at Emergent BioSolutions, Project Manager at Evonik, Principal Scientist at deCODE genetics, Group Leader at Advanced ChemTech, and Process Development Scientist at Borregaard Synthesis. Isaac holds a Doctor of Philosophy in Medicinal and Pharmaceutical Chemistry from the University of Ottawa and a postdoctoral fellowship in Bioorganic Chemistry from McMaster University.